Cell Therapy and Gene Therapy CDMO Market Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports

Cell Therapy and Gene Therapy CDMO Market Size

The global Cell Therapy and Gene Therapy CDMO market was valued at US$ 3120 million in 2023 and is anticipated to reach US$ 11110 million by 2030, witnessing a CAGR of 20.0% during the forecast period 2024-2030.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-4J16455/Global_Cell_Therapy_and_Gene_Therapy_CDMO_Market_Research_Report_2023

North American market for Cell Therapy and Gene Therapy CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cell Therapy and Gene Therapy CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Purchase Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-4J16455/Global_Cell_Therapy_and_Gene_Therapy_CDMO_Market_Research_Report_2023

The global market for Cell Therapy and Gene Therapy CDMO in Clinical Stage Projects is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cell Therapy and Gene Therapy CDMO include Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec and He Yuan Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell Therapy and Gene Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy and Gene Therapy CDMO.

By Type
• Cell Therapy
• Gene Therapy

By Application
• Clinical Stage Projects
• Commercialization Stage Projects

Key Companies
Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec, He Yuan Biology, GenScript Biotech, Kanglong Chemical, Porton shares, Sano Biologics, Yunzhou Biology

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-4J16455/global-cell-therapy-and-gene-therapy-cdmo

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.